• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Estimation of prognosis and prevalence of retinitis pigmentosa and Usher syndrome in Norway.

作者信息

Grøndahl J

出版信息

Clin Genet. 1987 Apr;31(4):255-64. doi: 10.1111/j.1399-0004.1987.tb02804.x.

DOI:10.1111/j.1399-0004.1987.tb02804.x
PMID:3594933
Abstract

Retinitis pigmentosa was diagnosed in 101 persons from 53 families. The prognosis for visual function was most favourable for the autosomal dominant group (38 patients from 8 families). The autosomal recessive group (40 patients from 25 families) and the 19 solitary cases were very heterogeneous, with prognosis ranging from favourable to very bad. There was a higher intrafamiliar correlation in the autosomal recessive than in the autosomal dominant group. In 28 patients from 18 families with Usher syndrome, almost all had good visual function until 30 years of age, and few had useful visual function after the age of 50. The age when the patients were registered varied between the different genetic types of retinitis pigmentosa, reflecting differences in prognosis. Therefore, ascertainment probability and prevalence were calculated for each genetic group separately. The prevalence of retinitis pigmentosa in Norway, all genetic groups included, was calculated to be 1/4440, the autosomal dominant type of the disease being the most frequent. The prevalence of Usher syndrome was calculated to be 3.6/100,000. Both retinitis pigmentosa and Usher syndrome were more prevalent in Laps.

摘要

相似文献

1
Estimation of prognosis and prevalence of retinitis pigmentosa and Usher syndrome in Norway.
Clin Genet. 1987 Apr;31(4):255-64. doi: 10.1111/j.1399-0004.1987.tb02804.x.
2
Prevalence of retinitis pigmentosa in Maine.缅因州视网膜色素变性的患病率。
Am J Ophthalmol. 1984 Mar;97(3):357-65. doi: 10.1016/0002-9394(84)90636-6.
3
Retinitis pigmentosa in Spain. The Spanish Multicentric and Multidisciplinary Group for Research into Retinitis Pigmentosa.西班牙的色素性视网膜炎。西班牙色素性视网膜炎多中心多学科研究小组。
Clin Genet. 1995 Sep;48(3):120-2.
4
Epidemiology of retinitis pigmentosa in the Valencian community (Spain).西班牙巴伦西亚自治区视网膜色素变性的流行病学
Genet Epidemiol. 1995;12(1):37-46. doi: 10.1002/gepi.1370120105.
5
Visual Prognosis in USH2A-Associated Retinitis Pigmentosa Is Worse for Patients with Usher Syndrome Type IIa Than for Those with Nonsyndromic Retinitis Pigmentosa.USH2A 相关性视网膜色素变性的视觉预后对 Usher 综合征 IIa 型患者比非综合征性视网膜色素变性患者更差。
Ophthalmology. 2016 May;123(5):1151-60. doi: 10.1016/j.ophtha.2016.01.021. Epub 2016 Feb 27.
6
Usher syndrome in four Norwegian counties.挪威四个郡的尤塞氏综合征
Clin Genet. 1986 Jul;30(1):14-28. doi: 10.1111/j.1399-0004.1986.tb00564.x.
7
Multicenter genetic study of retinitis pigmentosa in Japan: II. Prevalence of autosomal recessive retinitis pigmentosa.日本视网膜色素变性的多中心遗传学研究:II. 常染色体隐性视网膜色素变性的患病率。
Jpn J Ophthalmol. 1997 Jan-Feb;41(1):7-11. doi: 10.1016/s0021-5155(96)00019-6.
8
Usher syndrome in the city of Birmingham--prevalence and clinical classification.伯明翰市的Usher综合征——患病率及临床分类
Br J Ophthalmol. 1997 Jan;81(1):46-53. doi: 10.1136/bjo.81.1.46.
9
Retinitis pigmentosa: genetic mapping in X-linked and autosomal forms of the disease.视网膜色素变性:该疾病X连锁和常染色体形式的基因定位
Clin Genet. 1990 Jul;38(1):1-13. doi: 10.1111/j.1399-0004.1990.tb03541.x.
10
Prevalence of retinitis pigmentosa in Slovenia.斯洛文尼亚视网膜色素变性的患病率。
Clin Genet. 1992 Sep;42(3):122-3. doi: 10.1111/j.1399-0004.1992.tb03222.x.

引用本文的文献

1
The incidence of visual impairment due to retinitis pigmentosa has declined in Finland over the last 40 years.在过去40年里,芬兰因色素性视网膜炎导致视力受损的发病率有所下降。
Acta Ophthalmol. 2025 Feb;103(1):85-92. doi: 10.1111/aos.16757. Epub 2024 Sep 27.
2
Genetic Analysis of 252 Index Cases with Inherited Retinal Diseases Using a Panel of 351 Retinal Genes.使用 351 个视网膜基因对 252 个遗传性视网膜疾病的索引病例进行基因分析。
Genes (Basel). 2024 Jul 16;15(7):926. doi: 10.3390/genes15070926.
3
Evaluating therapeutic potential of NR2E3 doses in the rd7 mouse model of retinal degeneration.
评估NR2E3剂量在视网膜变性rd7小鼠模型中的治疗潜力。
Sci Rep. 2024 Jul 17;14(1):16490. doi: 10.1038/s41598-024-67095-6.
4
Preclinical dose response study shows NR2E3 can attenuate retinal degeneration in the retinitis pigmentosa mouse model Rho.临床前剂量反应研究表明,NR2E3 可减轻 Rho 型色素性视网膜炎小鼠模型的视网膜变性。
Gene Ther. 2024 May;31(5-6):255-262. doi: 10.1038/s41434-024-00440-6. Epub 2024 Jan 26.
5
Prevalence of inherited retinal diseases in a large Egyptian cohort.埃及大样本人群中遗传性视网膜疾病的患病率。
BMC Ophthalmol. 2023 Oct 20;23(1):422. doi: 10.1186/s12886-023-03163-1.
6
Usher Syndrome on the Island of Ireland: A Genotype-Phenotype Review.爱尔兰岛的先天性耳聋-色素性视网膜炎综合征:一种基因型-表型研究。
Invest Ophthalmol Vis Sci. 2023 Jul 3;64(10):23. doi: 10.1167/iovs.64.10.23.
7
Voretigene Neparvovec for the Treatment of RPE65-associated Retinal Dystrophy: Consensus and Recommendations from the Korea RPE65-IRD Consensus Paper Committee.Voretigene Neparvovec 治疗 RPE65 相关视网膜营养不良:韩国 RPE65-IRD 共识文件委员会的共识和建议。
Korean J Ophthalmol. 2023 Apr;37(2):166-186. doi: 10.3341/kjo.2023.0008. Epub 2023 Mar 23.
8
Nanoparticles-mediated CRISPR-Cas9 gene therapy in inherited retinal diseases: applications, challenges, and emerging opportunities.纳米颗粒介导的 CRISPR-Cas9 基因治疗遗传性视网膜疾病:应用、挑战和新机遇。
J Nanobiotechnology. 2022 Dec 3;20(1):511. doi: 10.1186/s12951-022-01717-x.
9
Clinical applications of retinal gene therapies.视网膜基因疗法的临床应用。
Precis Clin Med. 2018 Jun;1(1):5-20. doi: 10.1093/pcmedi/pby004. Epub 2018 Jun 1.
10
Ultra-widefield fundus autofluorescence imaging in patients with autosomal recessive retinitis pigmentosa reveals a genotype-phenotype correlation.常染色体隐性遗传性视网膜色素变性患者的超广角眼底自发荧光成像揭示了基因型与表型的相关性。
Graefes Arch Clin Exp Ophthalmol. 2022 Nov;260(11):3471-3478. doi: 10.1007/s00417-022-05683-w. Epub 2022 May 2.